Johnson & Johnson (JNJ) Active, Shares Gain
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Johnson & Johnson (NYSE: JNJ) Active, Shares Gain
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Janssen Partners with University of Pennsylvania and Castleman Disease Collaborative Network to Launch First Global Patient Registry for Castleman Disease
- tronc (TRNC) Trades Lower as Gannett (GCI) Deal in Doubt as Banks Withdraw Funding - Bloomberg
- Johnson & Johnson to Participate in the 25th Annual Credit Suisse Health Care Conference